INFU:PA:PA-Lyxor US$ 10Y Inflation Expectations UCITS ETF - C-USD EUR (EUR)

ETF | Others |

Last Closing

USD 116.93

Change

0.00 (0.00)%

Market Cap

USD 0.21B

Volume

174.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.43 (+0.97%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+13.50 (+2.78%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+9.94 (+2.85%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.81 (+2.51%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+4.60 (+1.84%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+16.10 (+3.86%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+7.96 (+2.50%)

USD 7.49B
HHH:PA HSBC S&P 500 UCITS ETF

+1.39 (+2.84%)

USD 7.22B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.27 (+4.42%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+2.33 (+3.04%)

USD 5.38B

ETFs Containing INFU:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.31% 28% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.31% 28% F 32% F
Trailing 12 Months  
Capital Gain -2.48% 16% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.48% 15% F 40% F
Trailing 5 Years  
Capital Gain 30.55% 35% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.55% 33% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 8.57% 54% F 63% D
Dividend Return 8.57% 50% F 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.42% 72% C 85% B
Risk Adjusted Return 101.85% 83% B 90% A-
Market Capitalization 0.21B 43% F 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.